Back to results
US 5,310,901 AGranted
O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynlheteroarylrapamycin derivatives
AssigneeMerck & Co., Inc.
InventorsWilliam H. Parsons, Peter J. Sinclair, Frederick Wong, Matthew J. Wyvratt
Life of this patent
Estimating the term…
Abstract
O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylrapamycin derivatives of the general structural Formula I: ##STR1## have been prepared from suitable precursors by alkylation and/or arylation at C-42 and/or C-31. These compounds are useful in a mammalian host for the treatment of autoimmune diseases and diseases of inflammation, infectious diseases, the prevention of rejection of foreign organ transplants and the treatment of solid tumors.
Claims5
A compound of Formula I:
- ##STR17## or a pharmaceutically acceptable salt thereof, wherein:
- R.sup.1 is selected from:
- (1) heteroaryl, wherein heteroaryl is selected from the group consisting of ##STR18## wherein O is --N(X)--, --O--, or --S--;
- (2) substituted heteroaryl, wherein heteroaryl is as defined above, and in which the substituents are X, Y and Z;
- (3) heteroaryl-C.sub.1-10 alkyl, wherein heteroaryl is as defined above;
- (4) substituted heteroaryl-C.sub.1-10 alkyl, wherein heteroaryl is as defined above and in which the heteroaryl group is substituted by X, Y and Z and the alkyl portion may be substituted with one or more of the substituent(s) selected from:
- (a) hydroxy,
- (b) oxo,
- (c) C.sub.1-6 -alkoxy,
- (d) aryl-C.sub.1-3 alkoxy, wherein aryl is selected from the group consisting of phenyl and naphthyl,
- (e) substituted aryl-C.sub.1-3 alkoxy, wherein aryl is as defined above and in which the substituents on aryl are X, Y and Z,
- (f) unsubstituted or substituted aryloxy, in which the substituents on aryl are X, Y and Z,
- (g) --OCO--C.sub.1-6 alkyl,
- (h) --NR.sup.6 R.sup.7, wherein R.sup.6 and R.sup.7 are independently selected from
- (i) hydrogen,
- (ii) C.sub.1-10 alkyl unsubstituted or substituted with one or more of the substituent(s) selected from:
- (a') aryl, wherein aryl is as defined above and which is unsubstituted or substituted with X, Y and Z,
- (b') heteroaryl, wherein heteroaryl is as defined above and which is unsubstituted or substituted with X, Y and Z,
- (c') --OH,
- (d') C.sub.1-6 alkoxy,
- (e') --CO.sub.2 H,
- (f') --CO.sub.2 --C.sub.1-6 alkyl,
- (g') --C.sub.3-7 cycloalkyl, and
- (h') --OR.sup.11,
- (iii) C.sub.3-10 alkenyl unsubstituted or substituted with one or more of the substituent(s) selected from:
- (a') aryl, wherein aryl is as defined above and which is unsubstituted or substituted with X, Y and Z,
- (b') heteroaryl, wherein heteroaryl is as defined above and which is unsubstituted or substituted with X, Y and Z,
- (c') --OH,
- (d') C.sub.1-6 alkoxy,
- (e') --CO.sub.2 H,
- (f') --CO.sub.2 --C.sub.1-6 alkyl,
- (g') --C.sub.3-7 cycloalkyl, and
- (h') --OR.sup.11,
- (iv) or where R.sup.6 and R.sup.7 and the N to which they are attached may form a heterocyclic ring selected from the group consisting of:
- morpholine, thiomorpholine, piperidine, and piperazine,
- (i) --NR.sup.6 CO--C.sub.1-6 alkyl-R.sup.7, wherein R.sup.6 and R.sup.7 are as defined above,
- (j) --NR.sup.6 CO.sub.2 --C.sub.1-6 alkyl-R.sup.7,
- (k) --NR.sup.6 CONR.sup.6 R.sup.7,
- (l) --OCONR.sup.6 R.sup.7,
- (m) --COOR.sup.6,
- (n) --CHO,
- (o) aryl, wherein aryl is as defined above,
- (p) substituted aryl wherein aryl is as defined above and in which the substituents are X, Y and Z,
- (q) --OR.sup.11, and
- (r) --S(O).sub.p --C.sub.1-6 alkyl;
- (5) heteroaryl-C.sub.1-10 alkyl wherein heteroaryl is as defined above and one or more of the alkyl carbons is replaced by a group selected from:
- --NR.sup.6 --, --O--, --S(O).sub.p --, --CO.sub.2 --, --O.sub.2 C--, --CONR.sup.6 --, --NR.sup.6 CO--, --NR.sup.6 CONR.sup.7 --;
- (6) substituted heteroaryl-C.sub.1-10 alkyl wherein heteroaryl is as defined above and one or more of the alkyl carbons is replaced by a group selected from:
- --NR.sup.6 --, --O--, --S(O).sub.p --, --CO.sub.2 --, --O.sub.2 C--, --CONR.sup.6 --, --NR.sup.6 CO--, and --NR.sup.6 CONR.sup.7 --, the heteroaryl group is substituted with X, Y, and Z, and the alkyl group may be substituted with one or more of the substituent(s) selected from:
- (a) hydroxy,
- (b) oxo,
- (c) C.sub.1-6 alkoxy,
- (d) aryl-C.sub.1-3 alkoxy, wherein aryl is as defined above,
- (e) substituted aryl-C.sub.1-3 alkoxy, wherein aryl is as defined above and in which the substituents on aryl are X, Y and Z,
- (f) unsubstituted or substituted aryloxy, wherein aryl is as defined above and in which the substituents on aryl are X, Y and Z,
- (g) --OCO--C.sub.1-6 alkyl,
- (h) --NR.sub.6 R.sup.7, wherein R.sup.6 and R.sup.7 are as defined above,
- (i) --NR.sup.6 CO--C.sub.1-6 alkyl-R.sup.7,
- (j) --NR.sup.6 CO.sub.2 --C.sub.1-6 alkyl-R.sup.7,
- (k) --NR.sup.6 CONR.sup.6 R.sup.7,
- (l) --OCONR.sup.6 R.sup.7,
- (m) --COOR.sup.6,
- (n) --CHO,
- (o) aryl, wherein aryl is as defined above,
- (p) substituted aryl wherein aryl is as defined above in which the substituents are X, Y and Z,
- (q) --OR.sup.11, and
- (r) --S(O).sub.p --C.sub.1-6 alkyl;
- (7) heteroaryl-C.sub.3-10 alkenyl wherein heteroaryl is as defined above and alkenyl contains one to four double bonds;
- (8) heteroaryl-C.sub.3-10 alkenyl wherein heteroaryl is as defined above and alkenyl contains one to four double bonds and wherein one or more of the alkyl carbons is replaced by a group selected from:
- --NR.sup.6 --, --O--, --S(O).sub.p --, --CO.sub.2 --, --O.sub.2 C--, --CONR.sup.6 --, --NR.sup.6 CO--, and --NR.sup.6 CONR.sup.7 --;
- (9) substituted heteroaryl-C.sub.3-10 alkenyl wherein heteroaryl is as defined above and alkenyl contains one to four double bonds and wherein one or more of the alkyl carbons may be replaced by a group selected from:
- --NR.sup.6 --, --O--, --S(O).sub.p --, --CO.sub.2 --, --O.sub.2 C--, --CONR.sup.6 --, --NR.sup.6 CO--, and --NR.sup.6 CONR.sup.7, the heteroaryl group is substituted with X, Y, and Z, and the alkyl group may be substituted with one or more of the substituent(s) selected from:
- (a) hydroxy,
- (b) oxo,
- (c) C.sub.1-6 alkoxy,
- (d) aryl-C.sub.1-3 alkoxy, wherein aryl is as defined above,
- (e) substituted aryl-C.sub.1-3 alkoxy, wherein aryl is as defined above and in which the substituents on aryl are X, Y and Z,
- (f) unsubstituted or substituted aryloxy, wherein aryl is defined above and in which the substituents on aryl are X, Y and Z,
- (g) --OCO--C.sub.1-6 alkyl,
- (h) --NR.sup.6 R.sup.7, wherein R.sup.6 and R.sup.7 as defined above,
- (i) --NR.sup.y CO--C.sub.1-6 alkyl, wherein R.sup.6 is as defined above,
- (j) --NR.sup.6 CO.sub.2 --C.sub.1-6 alkyl,
- (k) --NR.sup.6 CONR.sup.6 R.sup.7,
- (l) --OCONR.sup.6 R.sup.7,
- (m) --COOR.sup.6,
- (n) --CHO,
- (o) aryl, wherein aryl is as defined above,
- (p) substituted aryl wherein aryl is as defined above and in which the substituents are X, Y and Z, and
- (q) --OR.sup.11, and
- (r) --S(O).sub.p --C.sub.1-6 alkyl;
- R.sup.2 is selected from:
- (1) the definitions of R.sup.1 ;
- (2) hydrogen;
- (3) phenyl;
- (4) substituted phenyl in which the substituents are X, Y and Z;
- (5) 1-or 2-naphthyl;
- (6) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z;
- (7) biphenyl;
- (8) substituted biphenyl in which the substituents are X, Y and Z;
- (9) C.sub.1-10 alkyl;
- (10) substituted-C.sub.1-10 alkyl in which one or more substituent(s) is(are) selected from:
- (a) hydroxy,
- (b) oxo,
- (c) C.sub.1-6 alkoxy,
- (d) aryl-C.sub.1-3 alkoxy, wherein aryl is as defined above,
- (e) substituted aryl-C.sub.1-3 alkoxy, wherein aryl is as defined above and in which the substituents on aryl are X, Y and Z,
- (f) unsubstituted or substituted aryloxy, in which the substituents on aryl are X, Y and Z,
- (g) --OCO--C.sub.1-6 alkyl,
- (h) --NR.sup.6 R.sup.7, wherein R.sup.6 and R.sup.7 are as defined above
- (i) --NR.sup.6 CO--C.sub.1-6 alkyl-R.sup.7, wherein R.sup.6 and R.sup.7 is as defined above,
- (j) --COOR.sup.6, wherein R.sup.6 is as defined above,
- (k) --CHO,
- (l) phenyl,
- (m) substituted phenyl in which the substituents are X, Y and Z,
- (n) 1- or 2-naphthyl,
- (o) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z,
- (p) biphenyl,
- (q) substituted biphenyl in which the substituents are X, Y and Z,
- (r) --OR.sup.11, and
- (s) --S(O).sub.p --C.sub.1-6 alkyl;
- (11) C.sub.3-10 alkenyl;
- (12) substituted C.sub.3-10 alkenyl in which one or more substituent(s) is(are) selected from:
- (a) hydroxy,
- (b) oxo,
- (c) C.sub.1-6 alkoxy,
- (d) phenyl-C.sub.1-3 alkoxy,
- (e) substituted phenyl-C.sub.1-3 alkoxy, in which the substituents on phenyl are X, Y and Z,
- (f) --OCO--C.sub.1-6 alkyl,
- (g) --NR.sup.6 R.sup.7, wherein R.sup.6 and R.sup.7 are as defined above
- (h) --NR.sup.6 CO--C.sub.1-6 alkyl, wherein R.sup.6 is as defined above,
- (i) --COOR.sup.6, wherein R.sup.6 is as defined above,
- (j) --CHO,
- (k) phenyl,
- (l) substituted phenyl in which the substituents are X, Y and Z,
- (m) 1- or 2-naphthyl,
- (n) substituted 1- or 2-naphthyl in which the substituents are X, Y and Z,
- (o) biphenyl,
- (p) substituted biphenyl in which the substituents are X, Y and Z,
- (q) --OR.sup.11, and
- (r) --S(O).sub.p --C.sub.1-6 alkyl;
- (13) C.sub.3-10 alkynyl;
- (14) substituted C.sub.3-10 alkynyl in which one or more substituent(s) is(are) selected from:
- (a) hydroxy,
- (b) oxo,
- (c) C.sub.1-6 alkoxy,
- (d) phenyl-C.sub.1-3 alkoxy,
- (e) substituted phenyl-C.sub.1-3 alkoxy, in which the substituents on phenyl are X, Y and Z,
- (f) --OCO--C.sub.1-6 alkyl,
- (g) --NR.sup.6 R.sup.7, wherein R.sup.6 and R.sup.7 are as defined above,
- (h) --NR.sup.6 CO--C.sub.1-6 alkyl, wherein R.sup.6 is as defined above,
- (i) --COOR.sup.6, wherein R.sup.6 is as defined above,
- (j) --CHO,
- (k) phenyl,
- (l) substituted phenyl in which the substituents are X, Y and Z,
- (m) 1- or 2-naphthyl,
- (n) substituted 1-or 2-naphthyl in which the substituents are X, Y and Z,
- (o) biphenyl,
- (p) substituted biphenyl in which the substituents are X, Y and Z,
- (q) --OR.sup.11 ;
- and
- (15) --R.sup.11 ;
- R.sup.11 is selected from:
- (a) --PO(OH)O.sup.- M.sup.+, wherein M.sup.+ is a positively charged inorganic or organic counterion selected from the group consisting of:
- ammonium, sodium, lithium, potassium, calcium, magnesium, dicyclohexylamine, N-methyl-D-glucamine, arginine and lysine,
- (b) --SO.sub.3.sup.- M.sup.+,
- (c) --CO(CH.sub.2).sub.q CO.sub.2.sup.- M.sup.+, wherein q is 1-3, and
- (d) --CO--C.sub.1-6 alkyl-NR.sup.6 R.sup.7, wherein R.sup.6 and R.sup.7 are as defined above and the alkyl is unsubstituted or substituted with one or more substituents selected from:
- (i) hydroxy,
- (ii) C.sub.1-6 alkoxy,
- (iii) --NR.sup.16 R.sup.17, wherein R.sup.16 and R.sup.17 are independently selected from:
- (a') hydrogen, and
- (b') C.sub.1-6 alkyl,
- (iv) --COOR.sup.6, wherein R.sup.6 is as defined above,
- (v) phenyl,
- (iv) substituted phenyl in which the substituents are X, Y and Z,
- (vii) heteroaryl, wherein heteroaryl is as defined above,
- (viii) --SH, and
- (ix) --S--C.sub.1-6 alkyl;
- X, Y and Z independently are selected from:
- (a) hydrogen,
- (b) C.sub.1-10 alkyl, unsubstituted or substituted with one or more substituents selected from:
- (i) aryl, wherein aryl is as defined above,
- (ii) substituted aryl wherein aryl is as defined above and in which the substituents are X', Y' and Z',
- (iii) heteroaryl, wherein heteroaryl is as defined above,
- (iv) substituted heteroaryl wherein heteroaryl is s defined above and in which the substituents are X', Y', and Z',
- (v) unsubstituted or substituted aryloxy, wherein aryl is as defined above and in which the substituents on aryl are X', Y' and Z',
- (vi) --OR.sup.6,
- (vii) --OR.sup.11,
- (viii) --OCOR.sup.6,
- (ix) --OCO.sub.2 R.sup.6,
- (x) --NR.sup.6 R.sup.7,
- (xi) --CHO,
- (xii) --NR.sup.6 COC.sub.1-6 alkyl-R.sup.7,
- (xiii) --NR.sup.6 CO.sub.2 C.sub.1-6 alkyl-R.sup.7,
- (xiv) --NR.sup.6 CONR.sup.6 R.sup.7,
- (xv) --OCONR.sup.6 R.sup.7,
- (xvi) --CONR.sup.6 R.sup.7,
- (c) C.sub.1-10 alkyl wherein one or more of the alkyl carbons is replaced by a group selected from --NR.sup.6 --, --O--, --S(O).sub.p --, --CO.sub.2 --, --O.sub.2 C--, --CONR.sup.6 --, --NR.sup.6 CO--, --NR.sup.6 CONR.sup.7 --, --CO--, --CH(OH)--, alkenyl or alkynyl and the alkyl may be unsubstituted or substituted with one or more substituents selected from:
- (i) aryl, wherein aryl is as defined above,
- (ii) substituted aryl wherein aryl is as defined above and in which the substituents are X', Y' and Z',
- (iii) heteroaryl, wherein heteroaryl is as defined above,
- (iv) substituted heteroaryl wherein heteroaryl is as defined above and in which the substituents are X', Y', and Z',
- (v) unsubstituted or substituted aryloxy, wherein aryl is as defined above and in which the substituents on aryl are X', Y', and Z',
- (vi) --OR.sup.6,
- (vii) --OR.sup.11,
- (viii) --OCOR.sup.6,
- (ix) --OCO.sub.2 R.sup.6,
- (x) --NR.sup.6 R.sup.7,
- (xi) --CHO
- (xii) --NR.sup.6 COC.sub.1-6 alkyl-R.sup.7,
- (xiii) --NR.sup.6 CO.sub.2 C.sub.1-6 alkyl-R.sup.7,
- (xiv) --NR.sup.6 CONR.sup.6 R.sup.7,
- (xv) --OCONR.sup.6 R.sup.7,
- (xvi) --CONR.sup.6 R.sup.7,
- (d) halogen,
- (e) --NR.sup.6 R.sup.7,
- (f) --CN,
- (g) --CHO,
- (h) --CF.sub.3,
- (i) --SR.sup.8, wherein R.sup.8 is hydrogen, C.sub.1-6 alkyl, trifluoromethyl, or phenyl,
- (j) --SOR.sup.8,
- (k) --SO.sub.2 R.sup.8,
- (l) --CONR.sup.6 R.sup.7,
- (m) R.sup.9 O(CH.sub.2).sub.m - wherein R.sup.9 is hydrogen, C.sub.1-6 alkyl, hydroxy-C.sub.2-3 alkyl, --CF.sub.3, phenyl, R.sup.11 or naphthyl and m is 0, 1, 2, or 3,
- (n) --CH(OR.sup.12)(OR.sup.13), wherein R.sup.12 and R.sup.13 are C.sub.1-3 alkyl or taken together form an ethyl or propyl bridge,
- (o) ##STR19## wherein R.sup.9 and m are as defined above, (p) ##STR20## wherein R.sup.9 and m are as defined above, and (q) --R.sup.11 ;
- or any two of X, Y and Z may be joined to form a ring selected from the group consisting of dioxolanyl, and dioxanyl;
- X', Y' and Z' independently are selected from:
- (a) hydrogen,
- (b) C.sub.1-7 alkyl,
- (c) C.sub.2-6 alkenyl,
- (d) halogen,
- (e) --(CH.sub.2).sub.m --NR.sup.6 R.sup.7, wherein R.sup.6, R.sup.7 and m are as defined above,
- (f) --CN,
- (g) --CHO,
- (h) --CF.sub.3,
- (i) --SR.sup.8, wherein R.sup.8 is hydrogen, C.sub.1-6 alkyl, trifluoromethyl, or phenyl,
- (j) --SOR.sup.8, wherein R.sup.8 is as defined above,
- (k) --SO.sub.2 R.sup.8, wherein R.sup.8 is as defined above,
- (l) --CONR.sup.6 R.sup.7, wherein R.sup.6 and R.sup.7 are as defined above,
- (m) R.sup.9 O(CH.sub.2).sub.m - wherein R.sup.9 and m are as defined above,
- (n) --CH(OR.sup.12)(OR.sup.13), wherein R.sup.12 and R.sup.13 are as defined above,
- (o) ##STR21## wherein R.sup.9 and M are as defined above, (p) ##STR22## wherein R.sup.9 and M are as defined above, and (q) --R.sup.11.
240 more elements
A compound which is:
- ##STR25## wherein R.sup.1 and R.sup.2 are selected from the following combinations of substituents:
- __________________________________________________________________________ R.sup.1 R.sup.2 __________________________________________________________________________ (a) ##STR26## H (b) H ##STR27## (c) ##STR28## H (d) ##STR29## H (e) ##STR30## H (f) H ##STR31## (g) H ##STR32## (h) H ##STR33## (i) ##STR34## H (j) H ##STR35## (k) ##STR36## H (l) H ##STR37## (m) ##STR38## H (n) H ##STR39## (o) ##STR40## H (p) H ##STR41## __________________________________________________________________________
A compound which is:
- 42-(1-hydroxyethyl-indol-5-yl)oxy-rapamycin.
Dependencies are inferred from the claim text.